| 000 | 01807 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515051229.0 | ||
| 264 | 0 | _c20070329 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1043-6618 | ||
| 024 | 7 |
_a10.1016/j.phrs.2006.10.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTorii, Hiroaki | |
| 245 | 0 | 0 |
_aCilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation. _h[electronic resource] |
| 260 |
_bPharmacological research _cFeb 2007 |
||
| 300 |
_a104-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 |
_aAdherens Junctions _xdrug effects |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 |
_aCadherins _xmetabolism |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 | _aCilostazol |
| 650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aIntercellular Junctions _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOxygen _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aTight Junctions _xdrug effects |
| 650 | 0 | 4 | _aZonula Occludens-1 Protein |
| 650 | 0 | 4 | _aZonula Occludens-2 Protein |
| 700 | 1 | _aKubota, Hisashi | |
| 700 | 1 | _aIshihara, Hideyuki | |
| 700 | 1 | _aSuzuki, Michiyasu | |
| 773 | 0 |
_tPharmacological research _gvol. 55 _gno. 2 _gp. 104-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.phrs.2006.10.010 _zAvailable from publisher's website |
| 999 |
_c16726399 _d16726399 |
||